50.45

1.82% 0.90

Soleno Therapeutics Inc (SLNO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Soleno Therapeutics Inc stock is traded at $50.45, with a volume of 883.65K. It is up +1.82% in the last 24 hours and down -26.52% over the past month. Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Previous Close:

$49.55

Open:

$49.63

24h Volume:

883.65K

Relative Volume:

0.44

Market Cap:

$2.71B

Revenue:

Net Income/Loss:

$-38.99M

P/E Ratio:

-16.84

EPS:

-2.9966

Net Cash Flow:

$-24.94M

1W Performance:

+11.84%

1M Performance:

-26.52%

6M Performance:

-33.42%

1Y Performance:

-9.65%

1-Day Range:

$49.63

$51.11

1-Week Range:

$44.92

$51.60

52-Week Range:

$41.50

$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name

Soleno Therapeutics Inc

Sector

Healthcare (1139)

Industry

Biotechnology (638)

Phone

650-213-8444

Address

100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA

Employee

152

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

SLNO's Discussions on Twitter

Compare SLNO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLNO Soleno Therapeutics Inc	50.45	2.66B	0	-38.99M	-24.94M	-2.9966
VRTX Vertex Pharmaceuticals Inc	433.61	109.65B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	780.19	82.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	451.23	58.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	911.98	56.50B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	207.77	43.62B	447.02M	-1.18B	-906.14M	-6.1812

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Initiated	Wolfe Research	Outperform
Oct-07-25	Initiated	Goldman	Buy
Aug-20-25	Initiated	Wells Fargo	Overweight
Jun-23-25	Initiated	TD Cowen	Buy
Mar-05-25	Resumed	Stifel	Buy
Dec-02-24	Reiterated	Robert W. Baird	Outperform
Dec-02-24	Reiterated	Stifel	Buy
Sep-03-24	Initiated	H.C. Wainwright	Buy
May-10-24	Initiated	Robert W. Baird	Outperform
Feb-05-24	Initiated	Piper Sandler	Overweight
Jan-23-24	Initiated	Stifel	Buy
Nov-21-23	Resumed	Guggenheim	Buy
Sep-29-20	Initiated	Guggenheim	Buy
Jan-10-20	Initiated	Craig Hallum	Buy
Dec-23-19	Initiated	Oppenheimer	Outperform
Feb-13-18	Reiterated	Maxim Group	Buy

View All

Soleno Therapeutics Inc Stock (SLNO) Latest News

02:30 AM

Will Soleno Therapeutics Inc. stock recover faster than peers2025 Top Gainers & Precise Entry and Exit Recommendations - moha.gov.vn

02:30 AM

Nov 28, 2025

Will Soleno Therapeutics Inc. stock see insider buying2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025

Nov 26, 2025

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN

Nov 26, 2025

Nov 25, 2025

A Look at Soleno Therapeutics (SLNO) Valuation Following $100 Million Share Buyback Announcement - simplywall.st

Nov 25, 2025

Nov 24, 2025

Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire

Nov 24, 2025

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 24, 2025

Nov 23, 2025

9 Oversold Biotech Stocks to Invest In - Insider Monkey

Nov 23, 2025

Nov 21, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - Your Wyoming Link

Nov 21, 2025

Does Soleno Therapeutics Inc. (6XC) stock trade below intrinsic valueQuarterly Trade Summary & Intraday High Probability Alerts - newser.com

Nov 21, 2025

Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - Insider Monkey

Nov 21, 2025

Nov 20, 2025

Will Soleno Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com

Nov 20, 2025

Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickBond Market & Consistent Profit Trade Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Is Soleno Therapeutics Inc. stock trading near support levelsQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

How analysts revise price targets for Soleno Therapeutics Inc. (6XC) stock2025 Key Highlights & Smart Swing Trading Alerts - newser.com

Nov 19, 2025

Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsTrend Reversal & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025

Will Soleno Therapeutics Inc. (6XC) stock attract long term capital inflows2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025

Analyzing net buyer seller activity in Soleno Therapeutics Inc.Earnings Performance Report & Accurate Buy Signal Notifications - newser.com

Nov 19, 2025

Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - newser.com

Nov 19, 2025

Strategies to average down on Soleno Therapeutics Inc.Portfolio Return Report & Accurate Buy Signal Notifications - newser.com

Nov 19, 2025

Published on: 2025-11-19 04:05:29 - newser.com

Nov 19, 2025

Nov 18, 2025

Full technical analysis of Soleno Therapeutics Inc. stockQuarterly Market Review & Fast Gaining Stock Reports - newser.com

Nov 18, 2025

Wolfe Research Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform Recommendation - Nasdaq

Nov 18, 2025